• No results found

Anti Microbials

N/A
N/A
Protected

Academic year: 2021

Share "Anti Microbials"

Copied!
6
0
0

Loading.... (view fulltext now)

Full text

(1)

Antimicrobials Part 1 (Dr. Dando) ‘Twas the week b4 xmas vacation

Beta Lactam Compounds &

Other Inhibitors of Cell Wall Synthesis

• Penicillins

Cephalosporins & Cephamycins

• Other Beta Lactam Drugs o Monobactams

o Beta-Lactamase Inhibitors o Carbapenems

Other Inhibitors of Cell Wall Synthesis o Vancomycln o Teicoplanin o Fosfomycin o Bacitracin o Cycloserine Chloramphenicols Tetracyclines Macrolides • Erythromycin • Glarithromycin • Azithromycln Clindamycin Streptogramine • Quinupristin-dalfopristin Oxazoladinones • Linezolid

Beta Lactam Compounds & Other Inhibitors of Cell Wall Synthesis

- Penicillins and Cephalosporins are the major antibiotics that inhibit bacterial cell wall synthesis. They are called beta-lactams because of the unusual 4-member ring that is common to all their members.

A. Penicillins

• All peniclllins are derivatives of 6-emmopenicillanlc acid and contain a beta-lactam ring structure that is essential for antibacterial activity

Classification :

1.

Penicillins (e.g. PenicilIin G)

-

versus gram-posltive organisms, gram-negative cocci & non-beta lactamase anaerobes

2.

Antistaphylococcal penicillins (e.g. Nafcillin, Oxacillin, Cloxacillin, Dicloxacillin, etc.)

-

versus staphytococci and streptococci

3.

Extended-spectrum (e.g. Ampiciilin, Amoxicillin & Antipseudomonal Penicillins)

-

versus gram-negative organisms

-

drugs that retain the antibacterial spectrum of penicillin and have improved activity against gram-negative organIsms, but they are destroyed by beta-lactamases (penicllinases)

• Limitations:

- instability at acidic pH

- Susceptibility to destruction by bela-lactamase - Relative inactivity against gram-negative bacilli

• Units

-

PenG: 1600 unlts/mg(1M unit = 0.6g)

• Mechanism of Action

Inhibit bacterial cell wall synthesis (Class Ill reaction) by:

1.

binding of the drug to specific receptors (penicillin-

binding protelns [PBPs]) located in the bacterial cytoplasmic membrane

2.

inhibition of transpeptidase enzymes that act to cross-link linear peptidoglycan chains, which font part of the cell wall; Beta-lactams prevent the cross-linking peptides from binding to the tetrapeptide sidechains.

3.

activation of autolytic enzymes that cause lesions in the bacterial cell wall

Diagrams of sbucture and metabolism of a bacterial cell. A. Schematic representation of a bacterial cell. B. Flow diagram showing the synthesis of the irein types of macromolecule of a bacterial cell. Class I reactions result in the synthesis of the precursor molecules necessary for dat II reactions, which result in the synthesis of the constituent molecules; these are then anembled into macromolecules by dna Ill reactions

(2)

• Pharmacokinetics

- Oral absorption differs greatly for different penicillins, depending on acid stability and protein-binding (impaired by food, so, must be taken 1 hr before or after meals)

-

Widely distributed in the body fluids and tissues

-

Rapidly excreted by the kidneys

- Excreted Into sputum and milk

-

Poor penetration in the eye, prostate and CNS except with acute inflammation of meninges if given in high doses

- Normal half-life: approx. 30 mins

Clinical Uses of Penicillins :

-

Pen G (IV): drug of choice for infections caused by streptococci. meningococci, enterococci, pneumococci, non-beta-lactamase producing staphylococci

-

Pen V (oral): Indicated only for minor infections due to poor bioavailability

-

Benzathine/Procaine (IM): yield low but prolonged drug levels, for treatment of beta-hemolytic strep pharyngitis; IM inj every 21 days in RHD and as prophylaxis to prevent endocarditis

• ADR

-

Anaphylactic reaction (most serious and may happen even in therapeutic doses)

-

Seizures (overdose)

- Rashes, pruritus, urticaria in oral form

-

Hypotenslon, severe shock, circulatory collapse, death in IM form

Clinical Uses of Pen Resistant to Staph β -lactamase:

-

The sole indication is infection by beta-lactamase - producing staphylococci (Methicillin, Nafcillin)

-

For mild, local Infections:

lsoxazoyl (Oxacillin) - 15-25 mg/kg/d - For serious systemic staph infection:

Oxacillin or Nafclllin 8-12 g/d (50-100 mg/kg/d)

Clinical Uses of Extended Spectrum Penicillins:

-

Aminopenicillins (Amoxicillins), Carboxypenicillins (Ticarcillin), Ureidopenicillins (Piperacillin)

-

Greater activity against gram-negative bacteria

-

Amoxicillin is better absorbed from the gut - preferred preparation for oral penicillin

-

Ampicillin is effective for shigellosis but not for salmonellosis

-

For Pseudomonas: Carboxypenicillins + Aminoglycosides

-

Beta-lactamase Inhibitors (Clavulanic Acid, Sulbactam,

Tazobactam): versus beta-lactamase producing strains of Staph aureus

B. Cephalosporins

Are derivatives of 7-aminocephalosporanic acid and contain the beta-lactam ring structure

• Soluble In water

Stable to pH and temperature changes unlike Penicillins

Not active against enterococci and L. monocytoqenes

1.

First Generation Cephalosporins

-

Cefadroxil, Cefazolin (IV), Cephalexin (oral), Cephalotin, Cephapirin, Cephradine

- Greater activity for gram-negative microorganisms - Tubular secretory blocking agents (probenecid) may

increase serum levels

-

Cefazolln Is almost the only first generation parenteral cephalosporin: drug of choice for surgical prophylaxis alternative to an antistaphylococcal penicillin

-

Rarely the drug of choice for any Infection 2. Second Generation Cephalosporins

-

Cefaclor, Cefamandole, Cefonicid, Cefuroxime, Cefprozil, Loracarbef, Ceforanide, Cephamycins (Cefoxitin, Cefmetazole, Cefotetan)

-

Extended gram-negative coverage

-

Dose: (oral) 10-15 mg/kg/d BID

-

versus beta.-lactamase producing H. Influenza or Bhanhamella catarrhalis

-

Tx of sinusitis, otitis or lower RTI

-

Cefuroxlme: for community-acquired pneumonia; the only second-generation drug that crosses blood-brain barrier, but less effective in treatment of meningitis, than Ceftriaxone and Cefotaxime

3.

Third Generation Cephalosporlns

-

Cefoperazone, Cefotaxime, Ceftazidime (IV for meningitis), Ceftizoxime, Ceftriaxone (DOC: typhoid fever), Cefixime (oral), Cefpodoxime proxetil, Ceftibuten, Moxalactam

(3)

-

Expanded gram-negative coverage (except for Cefoperazone)

-

Some can cross blood brain barrier (Ceftriaxone and Cefotaxlme)

-

Active versus Citrobacter, Serratia & Providencia

-

Ceftazidime & Cefoperazone: vs P. aeroginosa

-

Ceftizoxime & Moxalactam: vs B. fragilis

-

Cefixime & Ceftriaxone: 1st line drug for tx of N.

gonorrhea

-

Cefixime, Ceftibuten, Cefpodoxine proxetil: are oral agents with similar activity except that Cefixime and Ceftibuten are much less active against Pneumococci and have poor activity against S. aureus

-

Ceftibuten (Cedax): newest oral cephalosporin with sImilar spectrum to Cefixime and Cefpodoxime; once-daily

-

Ceftriaxone and Cefotaxime most active vs. penicillin-resistant strains of Pneumococci and are recommended for empirical therapy of serious infections caused by these strains

4. Fourth Generation Cephalosporins

- Cepefime

- More resistant to hydrolysis by beta-lactamase

-

Active versus P. aeroginosa, Enterobacter, S. aureus, and S. pneumoniae

- Half life: 2 hours

• Adverse Effects - Allergy

- Toxicity – Renal, Hypoprothrombinemia,, severe disulfiram-like reactions

- Superinfection

• Oral Cephalosporins

C.

Other Beta-Lactams

1. Monobactam

Aztreonam vs gram-negative rods

-

resistant to beta-lactamases produced by certain gram-negative rods (Klebsiella, Pseudomonas, Serratia)

-

AE: GI upset with possible superinfection, vertigo,

headache, rare hepatotoxicity

-

Although skin rash may occur, there is no cross-allergenicity with penicillin

2. Beta-Lactamase InhIbItors

- Clavulanic acid, Sulbactam, Tazobactam

-

Treatment of mixed aerobic and anaerobic infections (lntra-abdominal infections)

-

are used in fixed combinations with certain hydrolyzable penicillins

3. Carbapenems

-

Imipenem, Meropenem, Ertapenem

-

Choice for treatment of infection caused by enterobacter

-

Chemically different from penicillins but retaining the

lactam ring structure with low susceptibility to beta-lactamase

- Wide activity against gram-positive cocci, gram-negative rods, and anaerobes

-

Imipenem is rapidly inactivated by renal dehydropeptldase I and Is administered in fixed combination with cilastatin, an inhibitor of this enzyme. Cilastatin increases the plasma half-life of imipenem and inhibits the formation of a potentially nephrotoxic metabolite

o

AE of Imipenem-cilastatin: GI distress, skin rash, and at very high plasma levels, CNS toxicity (confusion, encephalopathy, seizures). There is a partial cross-allergenicity with penicillin

-

Meropenem is similar to imipenem except that it is not metabolized by renal dehydropeptidases and is less likely to cause seizures

-

Ertapenem has a long half-life but it is less active against Pseudomonas, and its IM injection causes pain and irritation.

D. Other Inhibitors of Cell Wall Synthesis

1. Vancomycin

- For staphylococcal infection

-

Inhibits cell wall synthesis by binding firmly to the D-Ala-D-Ma terminus of nascent peptidoglycan pentapeptide - Poorly absorbed In GI

-

oral form used in tx of enterocolitis due to C. difficile

-

parenteral form indicated for sepsis, or endocarditis due

to MRSA

-

w/ gentarnlcln: as alternative regimen for treatment of enterococcal endocarditis in patient with serious penicillin allergy

-

Adverse Reaction: chills, fever, phlebitis, ototoxicity, and nephrotoxitity; Rapid IV infusion may cause “Red man” or “red neck” syndrome (diffuse flushings)

2. Telcoplanin

-

glycopeptide with similar MOA and antibacterial spectrum as vancomycin

3. Daptomycin

- Cyclic lipopeptide

-

Spectrum of activity similar to vancomycin but is active against vancomycin resistant strains of S. aureus

4. Fosfomycin

(4)

-

antimetaboiite inhibitor of cytosolic enolpyruvate transferase

-

tx of uncomplicated UTI

5. Bacltracin

- cyclic peptide

-

interferes with dephosphorylation in cycling of the lipid carrier and transfer of peptidoglycan subunits

- no cross-resistance

-

useful for suppression of mixed bacterial flora in surface lesions

-

limited to topical use because of its marked nephrotoxicity (proteinuria, hematuria. nitrogen retention)

6. Cycloserine

- water-soluble, unstable at acid pH

-

almost exclusively used to treat tuberculosis resistant to first-line agents

-

antimetabohte that blocks the incorporation of D-Ala into the pentapeptide side chain of the peptidoglycan

-

potentially neurotoxic (tremors, seizures. psychosis)

Resistance :

-

Inactivation by B lactamase - Modification of target PBPs

- Impaired penetration of drug to target PBPs - Presence of an efflux pump

Chloramphenicols

 Soluble in alcohol, neutral, stable

Potent inhibitor of microbial protein synthesis - bind to 50S subunit - inhibit peptidyl transferase

Bacteriostatic, broad-spectrum

Dose: 50-100 mg/kg/d

 Completely and rapidly absorbed orally  Used for eye infections

• Adverse Reactions:

-

GI disturbances

-

Bone marrow disturbances: aplastic anemia

-

Toxicity with newborn infants: Gray baby syndrome (lack of effective glucoronic acid conjugation)

-

Interaction with other drugs: Inhibits hepatic microsomal CYP450 enzymes

Tetracyclines

Broad spectrum bacteriostatic

• Inhibits protein synthesis - bind reversibly to 30S

Chelate divalent metal Ions

40-80% protein bound

Cross the placenta and excreted in milk

Choice for patient with renal insufficiency:

-

Doxycycline — once daily

DOC Mycoplasma pneumoniae, Chlamydiae, Rickettsiae, Spirochetes. Helicobacter pylori

Avoid In pregnant women and children below 8 years old, to avoid deposition In growing bones and teeth

Adverse reactions :

-

GI disturbances—from mild nausea and diarrhea to severe, possibly life-threatening colitis

-

Bony structures end teeth—tooth enamel dysplasia and irregular bone growth after to fetal exposure; tx of younger children may cause enamel dysplasia and crown deformation when permanent teeth appear

- Liver toxicity - Kidney toxicity

-

Local tissue toxicity - Photosensitization

-

Vestibular reactions—dose dependent dizziness and vertigo with doxycycline and minocycline

Macrolides

• Binds to 50s subunit of the ribosome

1. Erythromycln

-

Poorly soluble in water

-

Unstable at acid pH

-

Versus gram-positive organisms

-

Inhibitory or bactericidal

-

Inhibit protein synthesis via binding to 50S rRNA - Destroyed by stomach acid (needs enteric coating)

-

DOC: corynebactedal infection, respiratory, neonatal,

ocular/genital chlamydial infection, community-acquired pneumonia, alternative for penicillin-allergic individuals

-

Prophylaxis against endocarditis during dental

procedures with valvular heart disease

2. Clarithromycin

-

Derived from erythromycih by methyl group addition

-

Identical antibacterial activity with erythromycin

-

More active against Mycobacterium avium complex

-

250-500 mg BID

(5)

-

Laser frequency of GI intolerance

-

Less frequent dosing

3. Azithromycin

-

15-atom lactone ring derived from erythromycin by addition of methylated nitrogen

-

Highly active against chlamydia

-

Once-daily dosing and short duration of tx (3 days)

-

Given 1 hour before or after meals

-

Does not Inactivate cytochrome P450 enzymes

4. Ketolides

Telithromycin

- Semisynthetic 14-membered ring macrolide - Oral bioavailability: 57%

-

Once daily dose of 800 mg

Clindamycin

Chlorine-substituted lincomycin

• VS strep, staph, pneumococd

Inhibits protein synthesis by binding on the 50S subunit

For severe anaerobic infection due to bacteroides & other anaerobes

For prophylaxis of endocarditis with valvular heart disease undergoing dental procedures

10-20 mg/kg/d (0.15-0.3g every 8 hrs)

Newer Agents A. Streptogramins

Quinupristin-daltopristin

-

Bactericidal except Entrococcus faecium

-

lV 7.5 mg/kg every 8-12hrs

- AE pain at infusion site, athrelgla-myalgia syndrome

B. Oxazoladinones

LinezoIid

-

Bacteriostatic except for strep

-

Inhibits protein synthesis by binding on 23S ribosomal RNA of the 5OS subunit

- High oral bioavailability – 100%

-

Half-life: 4-6 hours

-

For vancomycin-resistant E. faecium - Toxicity: thrombocytopenia and neutropenia

• Mechanism of Action

Aminoglycosides

Bactericidal antibiotics obtained from Streptomyces sp

• Water-soluble, stable, more active at alkali pH

Irreversible inhibitors of protein synthesis — binds to specific 30S subunit ribosomal proteins

Absorbed poorly in GI tract

• Ototoxic and nephrotoxic

ADR: ototoxicity and nephrotoxicity; In high doses: curare-like effect with neuromuscular blockade

versus gram-negative enteric bacteria especially in bacteremia and sepsis (in neonates), in combination with vancomycin or with penicillin for endocarditis, and for TB treatment

• No oral preparation

Streptomycln - oldest aminoglycoside

Gentamycin, Tobramycin, Amikacin—only differ In side chain

• Mechanism of Action:

1. Streptomycin

-

Second line agent for tuberculosis tx

-

With penicillin: for enterococcal endocarditis

-

With tetracycline: tularemia, plague, brucellosis

-

Most serious toxic effect: vestibular disturbance — vertigo arid loss of balance

-

If given during pregnancy may cause deafness in newborn

(6)

-

vs gram-positive and gram-negative

-

No activity against anaerobes

-

For severe infections (sepsis and pneumonia) - 5-6 mg4cgd

3. Tobramycin

-

More active against pseudomonas

4. Amikacin

- For resistant organisms - 500mg BID IV

5. Netilmicin

- 5-7 mg/kg/d

6. Kanamycin & Neomycin

-

Bowel preparation for elective surgery

-

For topical and oral use only

7.

Spectinomycin

-

Alternative treatment for gonorrhea for peniciilin-aIIergic patients

-

2 g IM (40 mg/kg)

Mechanisms of Resistance : - Alteration of target

Modification to insensitivity to Inhibitor Reduction in physiologic Importance of target

Synthesis of new target enzyme that duplicates function of inhibited target

- Prevention of access to target Efflux of more drug than enters cell Failure of modified drug to enter cell - Inactivation of scent

Destruction of the agent

Modification of the agent so It fails to bind target

-

Failure to convert an inactive precursor agent to its active form

Quiz (2C):

1. MOA of penicillin: inhibit cell wall synthesis

2. MOA of chloramphenicol: inhibit protein synthesis by 50s 3. MOA of aminoglycoside: inhibit protein synthesis by 30s 4. ADR of aminoglycoside: ototoxicity

5. ADR of aminoglycoside: nephrotoxicity 6. Inflamed meninges: ceftriazone, penicillin 7. DOC for typhoid: chlroramphenicol

8. Most impt mode of inactivation: beta lactamases 9. ADR of vancomycin: red man

10. Prophylaxis for RHD with valvular churva: clinda/erythromycin

Haay, full effort tong trans na to….

Siguro naman this time papasa na kau ng pharma =p Brim, print mo 2, may kulang sa old trans

References

Related documents

In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs. Antimicrob

Chlozolinate showed a high degree of protectant and systemic activity against dicarboximide susceptible strains but was poor on low-level resistant strains.. PP192

The antimicrobial activity of the compound was assessed against ten bacterial strains that include Gram-positive bacteria viz Staphylococcus citreus, Methicillin resistant

Moreover the emergence of multiple drug‐resistant strains and, more recently, extensively drug‐ resistant (XDR‐TB) strains makes the discovery and the development

In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs. Antimicrob

Daptomycin, a cyclic lipopeptide with activity against most Gram-positive pathogens, including vancomycin-resistant enterococci and methi- cillin-resistant Staphylococcus aureus, is

Chapter 5: Activity of the Most Active Compounds Against Resistant Strains, Preliminary Cytotoxicity Data, Preliminary In Vivo Data, Mechanism of Action Studies,

The results obtained revealed anti-pathogenic activity of stem bark extract of Dacryodes edulis against Vancomycin Resistant Enterococci, Methicillin Resistant Staphylococcus